{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:30:55Z","timestamp":1791048655678,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.ygyno.2006.03.029","type":"journal-article","created":{"date-parts":[[2006,6,12]],"date-time":"2006-06-12T12:47:53Z","timestamp":1150116473000},"page":"307-314","source":"Crossref","is-referenced-by-count":78,"title":["Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia"],"prefix":"10.1016","volume":"103","author":[{"given":"A.","family":"Villavicencio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bacallao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Avellaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gabler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2006.03.029_bib1","series-title":"Polycystic ovary syndrome","first-page":"361","article-title":"Polycystic ovary syndrome: diagnostic criteria","author":"Chang","year":"2002"},{"key":"10.1016\/j.ygyno.2006.03.029_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ygyno.2006.03.029_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"Br Med J [Clin Res Ed]"},{"key":"10.1016\/j.ygyno.2006.03.029_bib4","first-page":"1024","article-title":"Recurrent early miscarriage and polycystic ovaries","volume":"297","author":"Sagle","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2006.03.029_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1471-0528.1993.tb12978.x","article-title":"Polycystic ovaries and levels of gonadotrophins and androgen in recurrent miscarriage: prospective study in 50 women","volume":"100","author":"Tulppala","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humupd\/7.6.522","article-title":"Polycystic ovary syndrome and cancer","volume":"7","author":"Balen","year":"2001","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ygyno.2006.03.029_bib7","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2006.03.029_bib8","first-page":"659","article-title":"Endometrial hyperplasia in young women","volume":"36","author":"Chamlian","year":"1970","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0029-7844(01)01432-6","article-title":"Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome","volume":"98","author":"Cheung","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib10","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diabetes.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.ygyno.2006.03.029_bib11","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S0002-9378(87)80258-2","article-title":"The effect of insulin on aromatase activity in isolated human endometrial glands and stroma","volume":"157","author":"Randolph","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0002-9378(98)70244-3","article-title":"Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture","volume":"179","author":"Nagamani","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ygyno.2006.03.029_bib14","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0029-7844(02)02628-5","article-title":"Polycystic ovary syndrome","volume":"100","author":"ACOG practice bulletin","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2006.03.029_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1210\/er.20.3.321","article-title":"Nuclear receptor coregulators: cellular and molecular biology","volume":"20","author":"McKenna","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ygyno.2006.03.029_bib17","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1210\/jc.87.6.2960","article-title":"Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium","volume":"87","author":"Gregory","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2006.03.029_bib18","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/molehr\/8.7.644","article-title":"Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during menstruation","volume":"8","author":"Wieser","year":"2002","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ygyno.2006.03.029_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jc.2002-020946","article-title":"Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium","volume":"88","author":"Shiozawa","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2006.03.029_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2003.10.007","article-title":"Expression of estrogen receptor coregulators in normal and malignant human endometrium","volume":"92","author":"Kershah","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib21","first-page":"885","article-title":"Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer","volume":"99","author":"Yeh","year":"2000","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.ygyno.2006.03.029_bib22","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1073\/pnas.93.11.5517","article-title":"Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells","volume":"93","author":"Yeh","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2006.03.029_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/me.13.1.117","article-title":"Interaction of the putative androgen receptor-specific coativator ARA70\/ELEI alpha with multiple steroid receptors and identification of an internally deleted ELEI beta isoforma","volume":"13","author":"Alen","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-1-7","article-title":"The roles of sex steroid receptor coregulators in cancer","volume":"1","author":"Gao","year":"2002","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ygyno.2006.03.029_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/me.12.4.513","article-title":"A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor","volume":"12","author":"Zhang","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib26","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1210\/me.2002-0089","article-title":"Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists","volume":"16","author":"Huang","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0955-0674(98)80014-8","article-title":"Co-activators and co-repressors in the integration of transcriptional responses","volume":"10","author":"Torchia","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(16)30062-0","article-title":"Dating the endometrial biopsy","volume":"1","author":"Noyes","year":"1950","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ygyno.2006.03.029_bib29","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1210\/jc.82.10.3509","article-title":"Tissue distribution of estrogen receptors alpha (ER-\u03b1) and (ER-\u03b2) mRNA in the midgestational human fetus","volume":"82","author":"Brandenberger","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2006.03.029_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1095\/biolreprod66.2.297","article-title":"Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome","volume":"66","author":"Apparao","year":"2002","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ygyno.2006.03.029_bib31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/jcem-67-2-334","article-title":"Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle","volume":"67","author":"Lessey","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2006.03.029_bib32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0015-0282(02)03304-6","article-title":"Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosis","volume":"78","author":"Castro","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ygyno.2006.03.029_bib33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1530\/rep.0.1220865","article-title":"Effect of nitric oxide on the expression of insulin-like growth factors and insulin-like growth factor binding proteins throughout the lifespan of the human corpus luteum","volume":"122","author":"I\u00f1iguez","year":"2001","journal-title":"Reproduction"},{"key":"10.1016\/j.ygyno.2006.03.029_bib34","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0092-8674(00)00188-4","article-title":"Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription","volume":"103","author":"Shang","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2006.03.029_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0960-0760(94)90020-5","article-title":"The effect of estrogen and androgen on androgen receptors and mRNA levels in uterine leiomyoma, myometrium and endometrium of human subjects","volume":"50","author":"Fujimoto","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0960-0760(00)00127-8","article-title":"Characterization of the androgen receptor in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa)","volume":"74","author":"Lovely","year":"2000","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ygyno.2006.03.029_bib37","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1210\/jc.86.6.2668","article-title":"Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium","volume":"86","author":"Slayden","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2006.03.029_bib38","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1073\/pnas.111150898","article-title":"A role for estrogen receptor \u03b2 in the regulation of growth of the ventral prostate","volume":"98","author":"Weihua","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.ygyno.2006.03.029_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1478-1336-2-3","article-title":"Estrogen receptor-dependent activation of AP-1 via non-genomic signaling","volume":"2","author":"Bjornstrom","year":"2004","journal-title":"Nucl Recept"},{"key":"10.1016\/j.ygyno.2006.03.029_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/er.23.2.175","article-title":"Androgen receptor (AR) coregulators: an overview","volume":"23","author":"Heinlein","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ygyno.2006.03.029_bib41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0039-128X(99)00107-5","article-title":"Estrogen receptor interaction with co-activators and co-repressors","volume":"65","author":"Klinge","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.ygyno.2006.03.029_bib42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1126\/science.277.5328.965","article-title":"AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer","volume":"277","author":"Anzick","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2006.03.029_bib43","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/cncr.10963","article-title":"Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray","volume":"95","author":"Wang","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.03.029_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/1097-0215(20000520)89:3<217::AID-IJC2>3.0.CO;2-6","article-title":"Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers","volume":"89","author":"Sakakura","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2006.03.029_bib45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccr.2004.06.027","article-title":"High tumor incidence and activation of the PI3K\/AKT pathway in transgenic mice define AIB1 as an oncogene","volume":"6","author":"Torres-Arzayus","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2006.03.029_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(00)00024-X","article-title":"The SRC family of nuclear receptor coactivators","volume":"245","author":"Leo","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.ygyno.2006.03.029_bib47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1017938608460","article-title":"Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers","volume":"67","author":"Kollara","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ygyno.2006.03.029_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1043-2760(01)00527-6","article-title":"Nuclear receptor coregulators: multiple modes of modification","volume":"13","author":"Hermanson","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2006.03.029_bib49","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/hmg\/8.9.1647","article-title":"Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin","volume":"8","author":"Boutell","year":"1999","journal-title":"Hum Mol Genet"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806002344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806002344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T17:23:01Z","timestamp":1547572981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825806002344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0090825806002344"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.03.029","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}